Bolus iron dosing may up infection, death risk in dialysis patients

06/21/2013 | HealthDay News

Researchers looked at data from more than 117,000 kidney dialysis patients and found that those who received large doses of intravenous iron over a short period of time were more likely to develop serious infections and suffer infection-related death than those who received maintenance dosing. The risks were especially high for patients who used a catheter or who had recently had an infection. The findings appear online in the Journal of the American Society of Nephrology.

View Full Article in:

HealthDay News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ